Financhill
Back

Kazia Therapeutics Stock Predictions

Kazia Therapeutics Stock Forecast

  • Over the next 52 weeks, Kazia Therapeutics has on average historically risen by 18.6% based on the past 25 years of stock performance.
  • Kazia Therapeutics has risen higher in 8 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 32%
  • Is Kazia Therapeutics Stock Undervalued?
    The current Kazia Therapeutics [KZIA] share price is $5.49. The Score for KZIA is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • KZIA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Kazia Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kazia Therapeutics has on average historically risen by 18.6% based on the past 25 years of stock performance.

Kazia Therapeutics Stock Rating

Buy
53
Kazia Therapeutics (KZIA) is a Buy

Is Kazia Therapeutics overpriced?

  • Kazia Therapeutics has risen higher in 8 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 32%

Kazia Therapeutics Stock Price History

Is KZIA stock going to rise?

  • The current trend is moderately bearish and KZIA is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Australia
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kaziatherapeutics.com

52-Week Data

52-Week High:
15.80
52-Week Low:
1.87

Prediction Charts

Market Cap:
23.91M
Price in USD:
5.49
Volume:
27.67K
Beta:
1.70

Technical Analysis

SMA50:
4.80
SMA100:
4.52
SMA200:
3.68
52-Wk Change:
-21.57%

Stock Predictions

  • Is Kazia Therapeutics stock public?
    Yes, Kazia Therapeutics is a publicly traded company.
  • What is the Kazia Therapeutics stock quote today?
    The Kazia Therapeutics stock price is 5.49 USD today.
  • How to buy Kazia Therapeutics stock online?
    You can buy Kazia Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-6 6.28 6.40 6.96 6.20
Nov-7 6.36 5.86 6.50 5.71
Nov-8 5.98 5.66 6.01 5.63
Nov-11 5.75 6.73 6.85 5.75
Nov-12 6.69 6.35 6.88 6.35
Nov-13 6.39 5.70 6.39 5.51
Nov-14 5.60 5.27 5.70 5.21
Nov-15 5.27 4.57 5.41 4.30
Nov-18 4.50 5.08 5.49 4.46
Nov-19 5.05 5.71 5.87 5.00
Nov-20 5.67 5.61 6.01 5.50
Nov-21 5.63 5.53 5.87 5.37
Nov-22 5.64 5.76 5.97 5.57
Nov-25 5.76 5.49 5.86 5.40

Kazia Therapeutics Earnings

Kazia Therapeutics Earnings Report: Per Share Kazia Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kazia Therapeutics Forecast Revenue Growth

Kazia Therapeutics Stock Analysis: Historical quarterly revenues per share for Kazia Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.01 per share.

* Kazia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.